Study in Subjects With Moderate Atopic Dermatitis

NCT03859986 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis Eczema

Interventions

DRUG: ALX-101 Gel Vehicle
DRUG: ALX-101 Gel 5%

Sponsor

Ralexar Therapeutics, Inc.